Skip to main content
SpringerLink
Log in

Methods of Cancer Diagnosis, Therapy and Prognosis

Gastrointestinal Cancer

  • Book
  • © 2009

Overview

Editors:
  1. M. A. Hayat

    1. Department of Biological Sciences, Kean University, Union, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • The only book that discusses cancer diagnosis, therapy, and prognosis together in one volume
  • Discusses the molecular processes that lead to the development and proliferation of cancer cells
  • Recent major advances in cancer diagnosis and therapy are included
  • The text is supported throughout with illustrations
  • The information identifies patients with high likelihood of clinical benefits from a specific treatment

Part of the book series: Methods of Cancer Diagnosis, Therapy and Prognosis (HAYAT, volume 3)

  • 14k Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (22 chapters)

  1. Front Matter

    Pages i-xxxi
    Download chapter PDF

  2. Gastrointestinal Cancers

    1. Introduction: Gastrointestinal Cancer

      • M. A. Hayat
      Pages 3-12

    2. Metastatic Gastrointestinal Cancer: Safety of Cisplatin Combined with Continuous 5-FU Versus Bolus 5-FU and Leucovorin (Methodology)

      • Jacqueline Duffour, Olivier Bouché, Philippe Rougier, Chantal Milan, Laurent Bedenne, Jean-François Seitz et al.
      Pages 13-21

    3. Gastrointestinal Cancer: Endoscopic Submucosal Dissection (Methodology)

      • Atsushi Imagawa
      Pages 23-28

    4. Gastrointestinal Epithelial Neoplasms: Endoscopic Submucosal Dissection (Methodology)

      • Mitsuhiro Fujishiro
      Pages 29-36

    5. Inoperable Abdomino-Pelvic Tumors: Treatment with Radio-Frequency Ablation and Surgical Debulking

      • Nathan W. Pearlman
      Pages 37-41

    6. Gastrointestinal Neuroendocrine Tumors: Diagnosis Using Gastrin Receptor Scintigraphy

      • Martin Gotthardt, Thomas M. Behr, Martin Béhé
      Pages 43-52

  3. Esophageal Cancer

    1. Distal Esophagus: Evaluation with 18F-FDG PET/CT Fusion Imaging

      • Domenico Rubello, Cristina Nanni
      Pages 55-61

    2. Endoscopic Ultrasound and Staging of Esophageal Cancer

      • Kanwar Rupinder S. Gill, Timothy A. Woodward
      Pages 63-75

    3. Esophageal Cancer: Role of RNASEN Protein and microRNA in Prognosis

      • Hideyuki Ishiguro, Yoshiyuki Kuwabara, Nobuyoshi Sugito, Yoshitaka Fujii
      Pages 77-81

    4. Esophageal Cancer: Initial Staging

      • Lana Y. Schumacher, Nicole B. Baril, Sherry M. Wren
      Pages 83-95

  4. Gastric Cancer

    1. Automated Disease Classification of Colon and Gastric Histological Samples Based on Digital Microscopy and Advanced Image Analysis

      • Levente Ficsor, Bela Molnar
      Pages 99-111

    2. Early Gastric Cancer: Prediction of Metachronous Recurrence Using Endoscopic Submucosal Dissection (Methodology)

      • Hiroshi Yokozaki, Tadateru Hasuo, Shin-ya Satake, Yasuhiro Omori, Naoko Maeda, Korefumi Nakamura et al.
      Pages 113-120

    3. Helicobacter pylori-Infected Neoplastic Gastric Epithelium: Expression of MUC2 as a Biomarker

      • Halagowder Devaraj, A. Anand Kumar, Niranjali Devaraj
      Pages 121-136

    4. Gastric Cancer: Role of Intestinal Metaplasia by Histochemical Detection Using Biopsy Specimens

      • Akiko Shiotani, Ken Haruma, David Y. Graham
      Pages 137-151

    5. Gastric Cancer: Antitumor Activity of RUNX3

      • Zhihai Peng, Keping Xie
      Pages 153-162

    6. Early Gastric Cancer: Laparoscopic Gastrectomy (Methodology)

      • Seigo Kitano, Kazuhiro Yasuda, Norio Shiraishi
      Pages 163-170

    7. Gastric Cancer: Overexpression of Hypoxia-Inducible Factor 1 as a Prognostic Factor

      • Yoshihiro Kakeji, Eiji Oki, Noriaki Sadanaga, Masaru Morita, Yoshihiko Maehara
      Pages 171-180

  5. Pancreatic Cancer

    1. Pancreatic Cancer: Hepatoma-Derived Growth Factor as a Prognostic Factor

      • Yasuhiko Tomita, Hirokazu Uyama, Hideji Nakamura
      Pages 183-189

    2. Pancreatic Cancer: 18F-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Parameter

      • Tatsuya Higashi
      Pages 191-203
Back to top

Keywords

About this book

Each year, tens of millions of people are respectively. The following data indicate diagnosed worldwide with cancer, and the burden (seriousness) of gastrointestinal more than half of these patients eventu- cancer, liver cancer, and colorectal cancers ally die from this disease. The severity of globally and in the United States. (Table 1) the burden of cancer becomes really clear Surgical and molecular therapies and pr- by knowing that there were ? 10, 862, 496 nostic markers for gastrointestinal stromal new cancer cases (excluding skin cancer) tumors are discussed in this volume. Role in the world in 2002, and the number of of anticancer drugs and monoclonal an- deaths caused by this disease in the same bodies specific for these tumors are also year was ? 6,723,887 (GLOBOCAN). discussed. Imaging modality assessing the The number of deaths due to cancer in the effect of anticancer imatinib on these tumors United States was estimated to be 559, 650 is included. Diagnostic and prognostic (Am. Cancer Soc. ). Cancer is caused by markers of clinical outcomes using che- both external factors (tobacco, chemicals, therapy and hormone replacement therapy radiation, and infectious organisms) and for gastric adenocarcinoma are detailed. internal factors (inherited mutations, hor- Also, are discussed immunohistochem- mones, immune conditions, and mutations try of esophageal cancer progression, and that occur from metabolism). diagnostic and therapeutic methodologies All cancer types caused by cigarette for biliary tumors.

Editors and Affiliations

  • Department of Biological Sciences, Kean University, Union, USA

    M. A. Hayat

Bibliographic Information

  • Book Title: Methods of Cancer Diagnosis, Therapy and Prognosis

  • Book Subtitle: Gastrointestinal Cancer

  • Editors: M. A. Hayat

  • Series Title: Methods of Cancer Diagnosis, Therapy and Prognosis

  • DOI: https://doi.org/10.1007/978-1-4020-8900-8

  • Publisher: Springer Dordrecht

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media B.V. 2009

  • Hardcover ISBN: 978-1-4020-8899-5Published: 01 December 2008

  • Softcover ISBN: 978-90-481-8021-9Published: 16 November 2010

  • eBook ISBN: 978-1-4020-8900-8Published: 21 December 2008

  • Edition Number: 1

  • Number of Pages: XXXI, 247

  • Topics: Cancer Research, Oncology, Surgical Oncology, Nursing, Radiotherapy

Publish with us

Policies and ethics

Back to top

Search

Navigation